2006
DOI: 10.1007/s10719-006-9001-4
|View full text |Cite
|
Sign up to set email alerts
|

Interaction of N-linked glycans, having multivalent GlcNAc termini, with GM3 ganglioside

Abstract: GM3 ganglioside interacts specifically with complex-type N-linked glycans having multivalent GlcNAc termini, as shown for (1) and (2) below. (1) Oligosaccharides (OS) isolated from ConA-non-binding N-linked glycans of ovalbumin, whose structures were identified as penta-antennary complex-type with bisecting GlcNAc, having five or six GlcNAc termini (OS B1, B2), or bi-antennary complex-type having two GlcNAc termini (OS I). OS I is a structure not previously described. (2) Multi-antennary complex-type N-linked … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
20
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
7
3

Relationship

3
7

Authors

Journals

citations
Cited by 35 publications
(21 citation statements)
references
References 51 publications
(50 reference statements)
1
20
0
Order By: Relevance
“…For example, GM3 is known to interact with the extracellular domain of the epidermal growth factor receptor (EGFR) to inhibit receptor tyrosine kinase [29], but the mechanism and site of EGFR for such interaction has been unclear. GM3 was recently shown to interact with a specific N-linked glycan having multivalent GlcNAc termini [60]. The increased expression of N-glycans with GlcNAc termini in cells treated with swainsonine, which inhibits α-mannosidase-II, causing accumulation of hybridtype structures having GlcNAc termini, was closely associated with the inhibitory effect of GM3 on EGFR tyrosine kinase (Fig.…”
Section: Glycosynapse Modulated Cell Signaling Through Cis-ccimentioning
confidence: 84%
“…For example, GM3 is known to interact with the extracellular domain of the epidermal growth factor receptor (EGFR) to inhibit receptor tyrosine kinase [29], but the mechanism and site of EGFR for such interaction has been unclear. GM3 was recently shown to interact with a specific N-linked glycan having multivalent GlcNAc termini [60]. The increased expression of N-glycans with GlcNAc termini in cells treated with swainsonine, which inhibits α-mannosidase-II, causing accumulation of hybridtype structures having GlcNAc termini, was closely associated with the inhibitory effect of GM3 on EGFR tyrosine kinase (Fig.…”
Section: Glycosynapse Modulated Cell Signaling Through Cis-ccimentioning
confidence: 84%
“…Although it is unclear how GSLs influenced TCR signaling in the studies reported here, the ability of such lipids to affect other signaling entities is not without precedence. For example, GM3 has been reported to interact with the epidermal growth factor receptor via the N-acetylglucosamine moieties present on its oligosaccharide side chains (35,36). This association of GM3 with the receptor has been implicated as a potential mode by which its tyrosine kinase and signaling activities are modulated.…”
Section: Discussionmentioning
confidence: 99%
“…We found that GM3 bound strongly to a specific complex-type N-linked glycans with 5-6 GlcNAc termini (e.g., "Os. Fr.B"), to a lesser degree to glycans with 3-4 GlcNAc termini, and essentially did not bind to glycans with 2 GlcNAc termini [151]. GM3 interaction with EGFR, which has been known for years (see Sec.…”
Section: Cell Adhesion and Signal Transduction Mediated By Carbohymentioning
confidence: 92%